Deck 24: Drugs for Neurodegenerative Diseases
سؤال
سؤال
سؤال
سؤال
فتح الحزمة
قم بالتسجيل لفتح البطاقات في هذه المجموعة!
Unlock Deck
Unlock Deck
1/4
العب
ملء الشاشة (f)
Deck 24: Drugs for Neurodegenerative Diseases
1
Which action is responsible for the therapeutic effects of entacapone?
A) inhibition of monoamine oxidase-type B
B) stimulation of levodopa decarboxylation
C) decreased formation of 3-O-methyldopa
D) increased uptake of dopamine into the brain
E) increased release of dopamine from neurons
A) inhibition of monoamine oxidase-type B
B) stimulation of levodopa decarboxylation
C) decreased formation of 3-O-methyldopa
D) increased uptake of dopamine into the brain
E) increased release of dopamine from neurons
decreased formation of 3-O-methyldopa
2
Severe hypomobility ("freezing") reactions in advanced Parkinson's disease may respond rapidly after injection of which drug?
A) apomorphine
B) dopamine
C) ropinirole
D) benztropine
E) tizanidine
A) apomorphine
B) dopamine
C) ropinirole
D) benztropine
E) tizanidine
apomorphine
3
Which agent is useful in persons with multiple sclerosis because it serves as a decoy for myelin-damaging T cells?
A) mitoxantrone
B) natalizumab
C) interferon beta-1b
D) glatiramer
E) prednisone
A) mitoxantrone
B) natalizumab
C) interferon beta-1b
D) glatiramer
E) prednisone
glatiramer
4
Memantine is believed to benefit persons with Alzheimer's disease because of its ability to exert which action?
A) inhibit neurotransmitter degradation
B) increase neurotransmitter degradation
C) block neurotransmitter receptors
D) activate neurotransmitter receptors
E) block neurotransmitter reuptake
A) inhibit neurotransmitter degradation
B) increase neurotransmitter degradation
C) block neurotransmitter receptors
D) activate neurotransmitter receptors
E) block neurotransmitter reuptake
فتح الحزمة
افتح القفل للوصول البطاقات البالغ عددها 4 في هذه المجموعة.
فتح الحزمة
k this deck

